Also they have too much debt relative to revenue. The $6mill borrowed is at a rate just over 11%. That is a cost of just over $600k per year. Their margin last time I looked didn't cover their salaries as I remember. We can revisit that after the final report.
- Forums
- ASX - By Stock
- HIL
- Ann: Quarterly Report and Appendix 4C
Ann: Quarterly Report and Appendix 4C, page-7
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add HIL (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, CEO
James Graham
CEO
Previous Video
Next Video
SPONSORED BY The Market Online